Join a Research Study Investigating a Potential Medication That May Improve Social Communications and Interactions for Adolescents with Autism Spectrum Disorder (ASD).
Clinical trial participants should:
- Participants will be between 12-17 and have symptoms and/or a diagnosis of Autism
- The study will include 10 visits and 1 phone call over 25 weeks
- Studies are supervised by specially trained doctors and medical staff
- Study-related care and medication are provided at no cost (no insurance is needed)
Complete this short questionnaire to determine if your adolescent prequalifies. You’ll be contacted by study staff who can answer your questions before you decide to participate.
Sign Up
What happens if I fill out the pre-screening questionnaire? If you pass the initial study screener, we will match you to a study clinic location in your area. If there is not a current study for Autism Spectrum Disorder in your area, we may reach out to you in the future by email, phone or text to share information about new study opportunities.
Keep in mind that participation is entirely voluntary. If you do decide to take part in a study, you may change your mind about participating at any time.
About Autism Spectrum Disorder (ASD)
Autism, also known as Autism Spectrum Disorder (ASD), is a common neurodevelopmental disorder characterized by persistent repetitive patterns of behavior and difficulties with social communication and interaction.1
ASD is characterized by core features and common characteristics that include*:
- Repetitive/ restrictive behavior
- Depressed mood
- Decreased social responsiveness
- Difficulties with self-regulation
- Social difficulties
- Heightened anxiety
- Challenging behavior
*This is not an exhaustive list. There are many other characteristics that individuals with Autism may have.
Social difficulties of individuals with Autism have a major impact on the quality of life, yet there are currently no FDA-approved medications that effectively treat this core symptom.2
The IRIS study is evaluating an investigational medication to determine its effectiveness for improving the daily communication and social interactions of individuals with ASD.
Frequently Asked Questions
What is a Clinical Study?
A clinical study (also called a clinical trial, or a research study) is a medical study that helps to answer important questions about an investigational medication. An investigational medication is a medication that has not been approved to treat a condition. Studies are needed to understand whether an investigational medication works for a certain condition and determine if it is safe for individuals to take. All prescription medications must be tested in clinical studies before they can be approved and prescribed to patients.
Why are Clinical Research Studies Important?
A clinical research study is the process by which new and innovative medications, interventions and treatments are approved and brought to market so people can live happier and healthier lives.
What Else Do I Need to Consider?
The research team will be able to explain more about the investigational medication and what the Autism study will involve. It is up to the participant to decide if they would like to participate.
How Far is the Study Site?
We match you to a study site within a close travel distance from your home. If we are not running the study in your area currently, we will keep you in our database and reach out if a study site in your area becomes available. If at any time you decided you no longer want your information stored, you can opt out and we will delete your details.
About the IRIS Autism Spectrum Disorder Study
This study will enroll about 150 participants across 42 study sites to evaluate whether the investigational study medication improves the daily communications and social interactions of individuals with ASD. Participating in the study can include up to 10 visits at a study clinic and 1 phone call over approximately 25 weeks.
Participation in the study will include several phases over 25 weeks, including a screening, investigational random assignment, and medication safety follow-up period. Some participants will receive active study medication while some will receive a placebo (an oral tablet that will look and feel just like the study medication but will contain no active medication) to help identify medication effectiveness. Whether or not a participant receives placebo is randomly determined.
Potential study participants must:
- Be 12-17 years of age
- Have a diagnosis of Autism
- Have a parent or guardian available to assist during the study and attend clinic visits with their child/teen
